Market Insights into the Use of Humanized Models in Biopharmaceutical Safety Assessment

Global Humanized Mouse and Rat Model market was valued US $255 Mn in 2022 and is expected to reach ~US $465 Mn by 2032, growing at a CAGR of 6.2% during the forecast period 2023-2032
As the demand for more accurate and predictive preclinical models grows, the humanized mouse and rat model market is likely to witness continued expansion. The ongoing advancements in genetic engineering technologies, coupled with a deeper understanding of human biology, will contribute to the refinement and diversification of these models. Researchers and pharmaceutical companies alike recognize the importance of these models in advancing medical knowledge and developing innovative therapies, driving sustained growth in this dynamic market.